
Carvix SPAC Merger: A $1.0B Roll-Up With a Cash Clock
Carvix is a technology-enabled automotive platform going public through a merger with Crown Reserve Acquisition Corp. I (Nasdaq: CRAC). The deal is definitive, but the setup still hinges on redemptions, financing, and closing conditions before the combined company can list. The bull case is a fragmented market and a roll-up model; the bear case is dilution and execution risk.




